EP Patent

EP3409272B1 — Pharmaceutical composition comprising eltrombopag olamine, reducing sugar, and polymeric binder

Assigned to Alfred E Tiefenbacher GmbH and Co KG · Expires 2020-06-24 · 6y expired

What this patent protects

Patent listed against eltrombopag-olamine.

Drugs covered by this patent

eltrombopag-olamine (ELTROMBOPAG OLAMINE)

Patent Metadata

Patent number: EP3409272B1
Jurisdiction: EP
Classification: —
Expires: 2020-06-24
Drug substance claim: No
Drug product claim: No
Assignee: Alfred E Tiefenbacher GmbH and Co KG
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.